Annual report pursuant to Section 13 and 15(d)

ABEONA THERAPEUTICS LLC ACQUISITION (Tables)

v3.3.1.900
ABEONA THERAPEUTICS LLC ACQUISITION (Tables)
 12 Months Ended
Dec. 31, 2015
ABEONA THERAPEUTICS LLC ACQUISITION [Abstract]  
Schedule of purchase price allocation

The following purchase price allocation is as follows:

 

Total purchase price        
Initial consideration   $ 31,758,000  
Contingent consideration     6,489,000  
Total purchase price   $ 38,247,000  
         
Allocation of the purchase price        
Cash   $ 3,697,000  
Accounts receivable     1,000  
Prepaid expenses     28,000  
Property and equipment     51,000  
Other assets     1,000  
Accounts payable     (153,000 )
Total tangible assets     3,625,000  
         
Licensing agreement     2,156,000  
Goodwill     32,466,000  
         
Total net asset value   $ 38,247,000